Research and Innovation for Global Health Transformation

Building on our Global Health Research portfolio, NIHR Research and Innovation for Global Health Transformation (RIGHT) extends the reach of our support to address the health issues faced by Official Development Assistance (ODA)-eligible countries as given on the Organisation for Economic Cooperation and Development’s (OECD) Development Assistance Committee (DAC) list.

RIGHT funds cutting-edge interdisciplinary applied health research in key areas in ODA-eligible countries where a strategic and targeted investment can result in a transformative impact.

Through RIGHT, we want to:

  • Deliver research of primary benefit to the health and wealth of the poorest individuals living in ODA-eligible countries, typically through research for the prevention of ill health and optimal disease management
  • Strengthen capacity for research and knowledge exchange through equitable partnerships between researchers in the UK and ODA-eligible countries
  • Promote interdisciplinary approaches to working (including, but not limited to: clinical, health economics, statistics, qualitative and social sciences), to ensure that research objectives can be delivered

RIGHT calls are a two stage competition, with independent peer review and international panel assessment.  Applicants successful at Stage 1 and invited to submit a Stage 2 application will be eligible to apply for funding of up to £10,000 to support proposal and partnership development during the Stage 2 application drafting process.

Call 2

The amount of NIHR funding available for this competition is up to £15 million. Awards of typical range £3-5 million (maximum of £5 million) over 3-4 years are available for ODA-eligible research, starting January 2020.

Research area

  • Mental health research in ODA-eligible countries, through supporting applied research on the development and evaluation of interventions to improve outcomes for those affected by mental health issues.

The rationale and research focus for each key area to be addressed in Call 2 is provided in full in the Guidance for Applicants.

Call 2 competition dates:

  • Call launch – 3 January 2019
  • Deadline for receipt of Stage 1 applications via the online RMS system – 27 March 2019 (1pm)
  • Selection Panel review the applications and make recommendations – May 2019
  • Applicants notified of outcome of Stage 1 and PPDA – June 2019
  • Stage 2 opens for successful Stage 1 applicants – 17 June 2019

Research and Innovation for Global Health Transformation: Call 2 webinar

The webinar provided information on the aims, scope and eligibility of the call. Participants of the webinar had the opportunity to ask questions about the call in writing and the Global Health team answered during the webinar. The webinar was presented by Mike Rogers (Assistant Director, Infrastructure and Faculty/CCF Lead for Global Health, NIHR Central Commissioning Facility) and members of the NIHR CCF Global Health team.

Watch a recording of the webinar.

View the webinar slides

 


Call 1

The amount of NIHR funding available for this competition is up to £30 million. Awards will range between £3m-5m (maximum of £5m) over 3-4 years for ODA-eligible research.

Key research areas

  • Reducing the public health burden of epilepsy in ODA eligible countries
  • Infection-related cancers - improving prevention, diagnosis, treatment, access to services
  • Reducing the public health burden of severe stigmatising skin diseases

The rationale and research focus for each key area to be addressed in Call 1 is provided in full in the Guidance for Applicants - stage 1 and stage 2.

 


Proposal and Partnership Development Awards

All RIGHT applicants that are successful at Stage 1 and invited to submit a Stage 2 application are eligible to apply for a Proposal and Partnership Development Award (PPDA). PPDAs provide funding of up to £10,000 to support partnership development and the preparation of the full proposal to be submitted for Stage 2. For RIGHT Call 2, to be considered for a PPDA, applicants must complete a separate PPDA application at the SAME time as completing their RIGHT Stage 1 application and must be submitted at the same time as the Stage 1 application in the RMS; deadline Wednesday, 27 March 2019 at 1pm.

Please Note: NIHR may challenge PPDA proposed costs that it does not consider appropriate or does not offer Value for Money, for example Business Class travel. Applicants will be required to provide an invoice for actual spend and evidence of spend at the time of submitting the Stage 2 application. Lead Applicant organisations will need to pre-finance these activities once approved by NIHR.

 


Selection criteria

The selection criteria used by the Funding Committee at Stage 1 will be:

  • Relevance of the proposed research to the research requirement outlined in the Remit
  • Quality of the research design and work plan
  • Strength of the research team
  • Impact of the proposed work

The selection criteria used by the Funding Committee at Stage 2 will be:

  • Relevance of the proposed research to the research requirement outlined in the Remit
  • Quality of the research design and work plan
  • Quality of the proposed management arrangements
  • Strength of the research team
  • Impact of the proposed work
  • Value for money provided by the application
  • Community and public involvement, where relevant to the research question(s)
  • Equity of partnerships and approach to capacity building

 


Competition dates

 Call 1 Stage 1 PPDA Stage 2
(if invited)
Competition launch 21 June 2018 29 October 2018 29 October 2018
Submission deadline 01 August 2018 (1pm) 9 November 2018 28 January 2019 (1pm)
Submission outcome October 2018   May 2019

  

 Call 2 Stage 1 PPDA Stage 2 
(if invited)
Competition launch 03 January 2019 03 January 2019 17 June 2019
Submission deadline 27 March 2019 (1pm)  27 March 2019 (1pm) 05 September 2019 (1pm)
Submission outcome June 2019  June 2019 November 2019

 


Eligibility

Applications are invited from UK-based (England, Wales, Scotland, Northern Ireland) Higher Education Institutions, and research institutes. Non-UK institutions in High-Income Countries can be included in the application if there is a strong justification as to why the expertise they are bringing cannot be found in the UK or in an ODA-eligible country; evidence for this, needs to be provided in the application.

Applications from joint groupings of UK institutions will be considered, though a lead UK institution must be specified.

Please note that for RIGHT Call 2 applications, it is mandatory to include a co-applicant or Joint Lead Applicant in an ODA-eligible country relevant to the research proposal.

The research must be focused on improving the health and welfare of the poorest and most vulnerable people in ODA-eligible countries. In order to be eligible to receive ODA funding, applications must demonstrate how they meet ODA compliance criteria and outline:

  • Which country or countries on the DAC list of ODA-eligible countries will directly benefit?
  • How the application is directly and primarily relevant to the development challenges of those countries?
  • How the outcomes will promote the health and welfare of a country or countries on the DAC list?